Cost-effectiveness strategies to treat osteoporosis in elderly women

Southern Medical Journal
Alfred K PfisterShea A Duerring

Abstract

Comparing the cost-effectiveness of various antiosteoporotic drugs has not been defined. We determined the cost-effectiveness of calcitonin, raloxifene, bisphosphates and PTH in a base-case cohort of women aged 65 or older with osteoporosis. After bone densitometry, women were stratified into groups of treatment or no treatment. Our outcome goal was a value of dollars 100,000 or less per quality-adjusted life years (QALY). A sensitivity analysis varied nonvertebral fracture reduction and compliance between the two most effective strategies to test various cost per QALY thresholds. Bisphosphonates displayed the most favorable incremental cost saving and prevented more fractures in our base-case analysis. In a sensitivity analysis, virtually all values of bisphosphonates were under dollars 100,000 per QALY and parathyroid hormone (PTH) was between dollars 100,000 and dollars 200,000 per QALY. Only bisphosphonates are cost-effective for fracture prevention in osteoporotic women aged 65 or older and this economic advantage is also maintained in subsets who have a lower relative risk of future fracture.

References

Nov 1, 1992·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C CooperL J Melton
Feb 1, 1992·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·C CooperL J Melton
Oct 1, 1991·Archives of Internal Medicine·E A ChrischillesR B Wallace
Jun 1, 1991·Annals of Internal Medicine·P D RossR D Wasnich
Mar 23, 1995·The New England Journal of Medicine·S R CummingsT M Vogt
Jul 1, 1994·Bone·E ChrischillesR Wallace
Jan 1, 1996·Scandinavian Journal of Rheumatology·R Handa, J P Wali
Mar 1, 1997·Journal of the American Geriatrics Society·A BrainskyJ Magaziner
Mar 1, 1997·American Journal of Public Health·F D WolinskyT E Stump
Jan 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·N F RayL J Melton
May 13, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D M BlackS R Cummings
Jun 15, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·L J MeltonW M O'Fallon
Nov 9, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A CauleyD Black
Nov 23, 2000·The New England Journal of Medicine·P KannusI Vuori
Feb 15, 2001·The New England Journal of Medicine·M R McClungUNKNOWN Hip Intervention Program Study Group
Jul 11, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jonsson
Aug 31, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D M BlackO Johnell
Aug 31, 2001·Menopause : the Journal of the North American Menopause Society·J KayserA Pressman
Jan 12, 2002·JAMA : the Journal of the American Medical Association·Steven R CummingsUNKNOWN Multiple Outcomes of Raloxifene Evaluation (MORE) Trial
Mar 1, 2002·The New England Journal of Medicine·Ian R ReidPierre J Meunier
Jun 11, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Marjolein Van der KliftHuibert A P Pols
Jul 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·John A KanisAlan K Ogelsby
Sep 14, 2002·Endocrinology and Metabolism Clinics of North America·Gordon H GuyattClifford Rosen
Jan 3, 2003·The New England Journal of Medicine·Mary E Tinetti
Feb 11, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D O'GradaighJ E Compston
May 6, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·L J MeltonJ A Kanis
Jun 24, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L Joseph Melton
Jul 30, 2003·Archives of Internal Medicine·Peter A UbelA Mark Fendrick
Sep 2, 2003·The American Journal of Medicine·Anna N A TostesonBruce Ettinger
Sep 25, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·UNKNOWN Robert P. Heaney
Oct 3, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Alexandra PapaioannouCharlie H Goldsmith
Nov 1, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jonsson
Nov 11, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Yebin JiangErik F Eriksen
Nov 11, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Katie L StoneUNKNOWN Osteoporotic Fractures Research Group
Mar 19, 2004·The New England Journal of Medicine·Henry G BoneUNKNOWN Alendronate Phase III Osteoporosis Treatment Study Group
Jun 4, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jonsson
Nov 13, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Florent RichyJean-Yves Reginster
Jan 14, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Elizabeth Barrett-ConnorLouis M Sherwood
May 5, 2005·JAMA : the Journal of the American Medical Association·Jane A CauleySteven R Cummings

❮ Previous
Next ❯

Citations

Sep 21, 2006·BMC Musculoskeletal Disorders·Ping ZhangHiroki Yokota
Dec 20, 2008·Drugs·Stephanie K A BlickSusan J Keam
Jul 25, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Stephanie K A BlickSusan J Keam
Jun 21, 2011·Applied Health Economics and Health Policy·Dirk Mueller, Afschin Gandjour
Sep 12, 2007·Journal of the American Medical Directors Association·Hosam K Kamel
May 20, 2014·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Chia-Wei LinLesley Weaver
Nov 4, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Melissa ThompsonHans Peter Kruse
Mar 22, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Dirk MüllerAfschin Gandjour
Aug 5, 2017·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·T SaitoK C Chung
Oct 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Laura B Hansen
Apr 11, 2018·Frontiers in Pharmacology·Chen-He ZhouHao-Bo Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
John T SchousboeK E Ensrud
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Mickaël HiligsmannJean-Yves Reginster
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
John T SchousboeK E Ensrud
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
M Schwenkglenks, K Lippuner
© 2021 Meta ULC. All rights reserved